Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
21,259
Total Claims
$2.3M
Drug Cost
553
Beneficiaries
$4,204
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-65%
Opioid rate vs peers
1.3% vs 3.8% avg
+258%
Cost per patient vs peers
$4,204 vs $1,174 avg
+107%
Brand preference vs peers
18.3% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.3%
Opioid Rate
282
Opioid Claims
$2,376
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,871 claims · $2.0M
Generic: 17,226 claims · $356K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 251 | $258K |
| Dapagliflozin Propanediol | 295 | $198K |
| Fluticasone/Umeclidin/Vilanter | 162 | $123K |
| Insulin Detemir | 138 | $109K |
| Tirzepatide | 96 | $106K |
| Dulaglutide | 88 | $101K |
| Empagliflozin | 115 | $75K |
| Apixaban | 120 | $75K |
| Liraglutide | 63 | $75K |
| Sacubitril/Valsartan | 93 | $67K |
| Rivaroxaban | 92 | $59K |
| Budesonide/Glycopyr/Formoterol | 77 | $52K |
| Insulin Degludec | 45 | $42K |
| Evolocumab | 60 | $42K |
| Umeclidinium Brm/Vilanterol Tr | 71 | $37K |
Prescribing Profile
Patient Profile
70
Avg Age
60%
Female
1.30
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About